HIMS & HERS HEALTH INC (HIMS) Stock Analyst Earnings Estimates
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 526.916M 93.81% | 872M 65.49% | 1.477B 69.33% | 2.392B 62.00% | 2.874B 20.15% | 3.46B 20.39% | 3.985B 15.17% | 4.555B 14.30% | 6.174B 35.54% | 7.312B 18.43% | 8.652B 18.33% | |
| EBITDA YoY % growth | -58.904M 39.67% | -16.493M 72.00% | 85.092M 615.93% | 328.81M 286.42% | 425.29M 29.34% | 546.54M 28.51% | 727.16M 33.05% | 910.96M 25.28% | 1.339B 46.99% | 1.6B 19.49% | 1.902B 18.88% | |
| EBIT YoY % growth | -66.378M 34.74% | -26.008M 60.82% | 68.004M 361.47% | 176.59M 159.68% | 268.29M 51.93% | 351.48M 31.01% | 398.41M 13.35% | 520.71M 30.70% | 450.84M -13.42% | 561M 24.43% | N/A | |
| Operating Margin | -12.60% | -2.98% | 4.61% | 7.38% | 9.34% | 10.16% | 10.00% | 11.43% | 7.30% | 7.67% | N/A | |
| EPS YoY % growth | -0.32 42.75% | -0.11 65.63% | 0.54 590.91% | 0.68 26.18% | 0.97 41.92% | 1.29 33.04% | 2.41 87.12% | 3.09 28.39% | 3.97 28.38% | 5.10 28.53% | 6.55 28.40% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.16 -49.35% | 0.17 53.52% | 0.31 56.40% | 0.32 88.00% | 0.31 90.91% | 0.28 67.11% | 0.40 28.80% | 0.43 34.04% | 0.40 28.57% | 0.34 21.08% |
| Revenue Q2Q % growth | 594.45M 48.04% | 641.89M 33.41% | 698.45M 19.19% | 653.07M 19.87% | 677.55M 13.98% | 708.65M 10.40% | 749.87M 7.36% | 786.89M 20.49% | 823.23M 21.50% | 854.29M 20.55% |
| EBITDA Q2Q % growth | 78.796M 130.00% | 85.117M 113.61% | 96.725M 46.12% | 96.528M 28.83% | 95.157M 20.76% | 93.803M 10.20% | 124.25M 28.46% | 129.98M 34.66% | 124.05M 30.36% | 112.68M 20.12% |
| EBIT Q2Q % growth | 44.735M 92.56% | 53.124M 133.42% | 71.776M 23.92% | 77.768M 81.64% | 71.63M 60.12% | 61.466M 15.70% | 90.779M 26.48% | 96.465M 24.04% | 90.587M 26.47% | 79.162M 28.79% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.17 183.33% | 0.15 | 0.02 | 10.29% |
| Q1 2025 Q2Q % growth | 0.20 300.00% | 0.12 | 0.08 | 62.17% |
| Q4 2024 Q2Q % growth | 0.11 1,000.00% | 0.11 | 0.00 | 4.62% |
| Q3 2024 Q2Q % growth | 0.32 900.00% | 0.04 | 0.28 | 666.87% |
| Q2 2024 Q2Q % growth | 0.06 300.00% | 0.04 | 0.02 | 37.66% |
| Q1 2024 Q2Q % growth | 0.05 200.00% | 0.01 | 0.04 | 308.50% |
| Q4 2023 Q2Q % growth | 0.01 120.00% | -0.02 | 0.03 | 152.29% |
| Q3 2023 Q2Q % growth | -0.04 55.56% | -0.03 | -0.01 | -24.77% |
| Q2 2023 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 45.82% |
| Q1 2023 Q2Q % growth | -0.05 37.50% | -0.07 | 0.02 | 31.37% |
| Q4 2022 Q2Q % growth | -0.05 66.67% | -0.07 | 0.02 | 26.47% |
| Q3 2022 Q2Q % growth | -0.09 -13.92% | -0.10 | 0.01 | 13.49% |
| Q2 2022 Q2Q % growth | -0.10 -233.33% | -0.10 | 0.00 | 3.57% |
| Q1 2022 Q2Q % growth | -0.08 73.33% | -0.07 | -0.01 | -10.08% |
| Q4 2021 Q2Q % growth | -0.15 -114.29% | -0.07 | -0.08 | -102.84% |
| Q3 2021 Q2Q % growth | -0.08 | -0.06 | -0.02 | -25.59% |
| Q2 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 64.24% |
| Q1 2021 Q2Q % growth | -0.30 | -0.11 | -0.19 | -180.78% |
| Q4 2020 Q2Q % growth | -0.07 | -0.16 | 0.09 | 57.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 544.83M 72.61% | 562.65M | -17.82M | -3.17% |
| Q1 2025 Q2Q % growth | 586.01M 110.67% | 548.97M | 37.04M | 6.75% |
| Q4 2024 Q2Q % growth | 481.139M 95.45% | 479.72M | 1.419M | 0.30% |
| Q3 2024 Q2Q % growth | 401.556M 77.13% | 389.85M | 11.706M | 3.00% |
| Q2 2024 Q2Q % growth | 315.648M 51.82% | 305.94M | 9.708M | 3.17% |
| Q1 2024 Q2Q % growth | 278.171M 45.81% | 275.79M | 2.381M | 0.86% |
| Q4 2023 Q2Q % growth | 246.169M 47.23% | 251.38M | -5.211M | -2.07% |
| Q3 2023 Q2Q % growth | 226.699M 56.52% | 224.45M | 2.249M | 1.00% |
| Q2 2023 Q2Q % growth | 207.912M 83.08% | 209.06M | -1.148M | -0.55% |
| Q1 2023 Q2Q % growth | 190.77M 88.30% | 182.66M | 8.11M | 4.44% |
| Q4 2022 Q2Q % growth | 167.203M 97.41% | 164.39M | 2.813M | 1.71% |
| Q3 2022 Q2Q % growth | 144.836M 95.27% | 132.95M | 11.886M | 8.94% |
| Q2 2022 Q2Q % growth | 113.563M 87.11% | 105.96M | 7.603M | 7.18% |
| Q1 2022 Q2Q % growth | 101.314M 93.67% | 92.998M | 8.316M | 8.94% |
| Q4 2021 Q2Q % growth | 84.699M | 78.329M | 6.37M | 8.13% |
| Q3 2021 Q2Q % growth | 74.173M | 71.942M | 2.231M | 3.10% |
| Q2 2021 Q2Q % growth | 60.692M | 57.623M | 3.069M | 5.33% |
| Q1 2021 Q2Q % growth | 52.314M | 49.79M | 2.524M | 5.07% |
| Q4 2020 Q2Q % growth | 37.744M | -37.744M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.49% | 3.25% | -0.46% | 8.82% |
| Revenue | 0.33% | -2.63% | -0.25% | 0.76% |